That's great, because we have to get beyond temperature testing and just asking questions. As you said, testing asymptomatic people is really the key.
As we look at the second wave—I'll stay with you, David—you're also making ventilators. It hasn't come up in your presentation yet. It looks like we're going to have more ventilators than we need for this wave, but could you comment on the capacity for ventilators for the second wave and opportunities for export?